
IDEX Reports First Quarter Results
IDEX Corporation (NYSE: IEX) today announced its financial results for the three month period ended March 31, 2023. “The markets served by our Health & Science Technologies businesses have strong…

IDEX Corporation (NYSE: IEX) today announced its financial results for the three month period ended March 31, 2023. “The markets served by our Health & Science Technologies businesses have strong…

IDEX Corporation (NYSE:IEX) today announced it has entered into a definitive agreement to acquire Iridian Spectral Technologies (“Iridian”) for cash consideration of 150 million Canadian dollars (“CAD”), subject to customary adjustments.…

Today, leading all-in-one marketing solution for dental and medspa practices, Lasso MD, announced a $2M lead investment from Trestle Partners (“Trestle”), a New York-based private investment firm with significant expertise partnering…

A privately held company focused on innovative fluorescence-guided imaging technologies for cancer surgery, today announced that results of the Investigation of Novel Surgical Imaging for Tumor Excision (INSITE) pivotal trial…

Generate:Biomedicines and The University of Texas MD Anderson Cancer Center today announced a strategic collaboration to jointly discover and co-develop protein therapeutics for up to five oncology targets in advanced…

Azuba Corporation, www.azuba.com, announced the launch of their HIPAA-compliant Azuba Healthcare Platform with broad interoperability automation for all the 350,000+ health apps in the healthcare space at the annual HIMSS23 conference.…

The market leader in providing AI-powered and SaaS-based capacity management, staffing, and patient flow software for health systems, today announced it has been named the highest, fully-rated company in the…

Masimo (NASDAQ: MASI), a global leader in pulse oximetry and other innovative noninvasive monitoring technologies, today announced the launch of Stork, a revolutionary home baby monitoring system. This innovative system offers…

-Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary nanosecond pulsed field ablation (nsPFA™) technology and proprietary CellFX System® for the treatment of atrial fibrillation, today announced…

Surescripts, the nation’s leading health information network, will lead two sessions at the National Council for Prescription Drug Programs (NCPDP) Annual Technology & Business Conference on May 9, 2023, on Opportunities to Expand…

Nuvo Group Ltd. (“Nuvo” or “the Company”), the creators of INVU by Nuvo™, an FDA-cleared remote pregnancy monitoring platform, and LAMF Global Ventures Corp I (NASDAQ: LGVC) (“LAMF”), a special…

Dexcom, Inc. (NASDAQ : DXCM), un chef de file à l’échelle internationale dans le domaine de la surveillance du glucose en continu (SGC) et en temps réel pour les personnes…